CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
Monthly Archives: April 2014
Coming Soon: PeriRx LLC’s Breakthrough Salivary Test to Aid in the Fight Against Oral Cancer
The World’s Most Clinically Advanced and Scientifically Validated Molecular DNA Biomarker Test for Oral Squamous Cell Carcinoma is Launching in Late Spring
HAVERTOWN, PA–(Marketwired – Apr 3, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology recently announced that it will be introducing the world’s most clinically advanced and scientifically validated molecular DNA biomarker test for oral squamous cell carcinoma detection in the late spring. [Read more…]
Improving early detection of oral squamous cell carcinoma with advanced salivary diagnostics may impact mortality
Photo by Dreamstime.com
Oral cancer is the sixth most prevalent form of cancer in the United States. According to the Oral Cancer Foundation and the National Cancer Institute, approximately 43,000 people in the U.S. will be newly diagnosed with oral cancer in 2014. This includes those cancers that occur in the mouth itself, in the very back of the mouth, known as the oropharynx, and on the exterior lip of the mouth.
Oral cancer is also curable if detected early enough. [Read more…]